BioSpace News Archive

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 2, 2021 on Wednesday, May 5, 2021 after the market close. STAAR will host a conference call and webcast on Wednesday, May 5 at 4:30 p.m. Eastern / 1:30 p.m.

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced its Interactive Response Technology (IRT) solution has reached a significant milestone.

Translational Research In Oncology (TRIO) today announced completion of enrollment for Novartis phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC). The trial, referred to as NATALEE (New Adjuvant TriAl with LEE), has enrolled 5101 patients globally.